Biofrontera (NASDAQ:BFRI) Stock Price & Analysis

–

USD

–(–)

Open

$1.04

Prev. Close

$1.46

High

$1.18

Low

$1.03

Company Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

CEOHermann Lübbert

SectorHealthcare

IndustryMedical - Pharmaceuticals

Employees89

IPO DateOct 29, 2021

ExchangeNASDAQ

Exchange NameNASDAQ

CurrencyUSD

Headquarters & Contact

Address660 Main Street

City / State / ZIPWoburn, MA, 01801

CountryUnited States

Phone781 245 1325

Websitehttps://www.biofrontera-us.com

Biofrontera Inc.

Company Profile

Recently from Cashu